G
Gérard Mick
Publications - 6
Citations - 2317
Gérard Mick is an academic researcher. The author has contributed to research in topics: Neuropathic pain & Medicine. The author has an hindex of 3, co-authored 3 publications receiving 1953 citations.
Papers
More filters
Journal ArticleDOI
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)
Didier Bouhassira,Nadine Attal,Haiel Alchaar,François Boureau,Bruno Brochet,Jean Bruxelle,G. Cunin,Jacques Fermanian,Patrick Ginies,Aurélie Grun-Overdyking,Hélène Jafari-Schluep,Michel Lanteri-Minet,Bernard Laurent,Gérard Mick,Alain Serrie,Dominique Valade,Eric Vicaut +16 more
TL;DR: The 10‐item questionnaire developed in the present study constitutes a new diagnostic instrument, which might be helpful both in clinical research and daily practice and found that a relatively small number of items are sufficient to discriminate neuropathic pain.
Journal ArticleDOI
A prospective study of neuropathic pain induced by thoracotomy: incidence, clinical description, and diagnosis.
Virginie Guastella,Gérard Mick,Christophe Soriano,Laurent Vallet,Georges Escande,Claude Dubray,Claude Dubray,Alain Eschalier,Alain Eschalier +8 more
TL;DR: A minimal incidence of chronic post‐thoracotomy pain is indicated at 70% and that of neuropathic pain at 29%, the latter being clinically suggested by a combination of certain symptoms and reinforced by the DN4 questionnaire when sensory deficit at scar is present.
Journal ArticleDOI
Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria.
Françoise Radat,Christelle Créac’h,Evelyne Guegan-Massardier,Gérard Mick,Nathalie Guy,Nelly Fabre,Pierric Giraud,Fatima Nachit-Ouinekh,Michel Lanteri-Minet +8 more
TL;DR: The aim of this study was to assess behavioral dependence on migraine abortive drugs in medication‐overuse headache patients and identify the predisposing factors.
Journal ArticleDOI
Long-term prophylactic efficacy of transcranial direct current stimulation in chronic migraine. A randomised, patient-assessor blinded, sham-controlled trial
Hasan Hodaj,Jean François Payen,Gérard Mick,Laurent Vercueil,Enkelejda Hodaj,A. Dumolard,Bénédicte Noëlle,Chantal Delon-Martin,Jean-Pascal Lefaucheur +8 more
TL;DR: In this article , anodal tDCS of the left motor cortex in patients with resistant chronic migraine (CM) and its long-term maintenance was evaluated in a patient-assessor blinded, sham controlled trial.
Journal ArticleDOI
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
Caroline Papeix,Emmanuelle Leray,Pierre Levy,Jean Marc Visy,Gisela Kobelt,Fabienne Lamy,Bashar Allaf,François Heintzmann,I. Chouette,Eric Raponi,Barbara Durand,Emmanuelle Grevat,D. Kamar,Marc Debouverie,Christine Lebrun-Frenay,A. Abdelmoumni,Mouhmmad Jamal Al Aloucy,Abdullatif Al Khedr,Amer Al Najjar Carpentier,Bernard Alonzo,Tony Altarcha,Amevi Ananivi,Géraldine Androdias,G. Angibaud,M. Artaud-Uriot,D. Audry-Chaboud,M. Barré,Philippe Barres,Rabah Benrabah,Eric Berger,F.X. Bergouignan,Patricia Bernady,Christophe Billy,Christian Blanchard,Mickael Bonnan,J.P. Borsotti,Catherine Bossu-Van Nieuwenhuyse,J. Bouffeteau,S. Bouillaguet,Yassine Boukriche,Jean-Marc Boulesteix,Bertrand Bourre,David Brassat,A Bredin,Bruno Brochet,Helene Brugeilles Baguelin,Ousmane A Camara,Jean-Philippe Camdessanché,William Camu,Christophe Carel,Bertrand Carlander,Olivier Casez,Giovanni Castelnovo,Marie-Pierre Chanel-Soulier,Stéphane Chapuis,Mirella Cimpoesu,Jonathan Ciron,Pierre Clavelou,C. Clerc,R. Colamarino,Christophe Couratier,S. Courtois,M. Coustans,Alain Créange,Antoine Danielli,Thomas De Broucker,Jérôme De Seze,Gilles Defer,Jérôme Delorme,B. Denis,F Derouiche,Philippe Devos,Anne-Marie Deyrolle,Michel W. Dib,Joseph E. Dib,Eric Diot,E. Doury,S. Dufourd-Delalande,Corinne Dupel-Pottier,P Dussaux,Gilles Edan,Thibault Edouard,J. P. Escaillas,Didier Ferriby,N. Fouillet,Guillaume Fromager,Tsouria Gaida-Rostane,Philipp Gaida,G. Gal,Guillaume Garrigues,Annick Gayou-Joyeux,Arnaud Gentil,Philippe Gérard,Julien Gere,L. Gignoux,Philippe Girard,Pierric Giraud,Michel Gouttard,Pierre Gras,A.-M. Guennoc,M. Gugenheim,Laurent Guilloton,K. Hadjout,Patrick Hautecoeur,Yawo Hegbe,Olivier Heinzlef,P. Henry,Yann Herve,Jihad Hijazi,P Homeyer,Bernard Huttin,O. Ille,Alain Jager,Laurent Jomir,Nabil Kardous,Agnès Kerouanton,C. Kpade,Christophe Kubler,Pierre Labauge,François Lallement,N. Landragin,David Laplaud,Henda Laribi,G Lavernhe,Pierre-Éric Le Biez,Françoise Le Bras,Patrick Le Coz,Josette Leche,Sara Leder,A. Legout,M. Levasseur,Alberta Lorenzi-Pernot,P. Louchart,Fabien Louillet,Laurent Magy,S Maillard,Elisabeth Maillart,Marcel Maillet-Vioud,Catherine Mallecourt-Emberger,E. Manchon,A. Mania,L. Martinez-Almoyna,Mikel Martínez,Serge Aurelien Massengo,D. Maugin,S. Medjbeur,Gayané Meliksetyan,M. Menassa,Dalia Meshaka-Dimitri-Boulos,Gérard Mick,Thibault Moreau,Antoine Moulignier,Isabelle Mourand,James Muller,Philippe Neuschwander,A. Nibbio,Chantal Nifle,Jean-Bertin Nkendjuo,Ghislain Nokam Talom,Sophie Ory,Ivania Patry,Bernard Pedespan,Jean Pelletier,Delia-Gianina Pencu,B Perrouty,S. Peysson,Irène Popa-Coman,A. Pouliquen,Christophe Prat,Adriana Prundean,Fatai Radji,H. Rakotoharinandrasana,Lilia Razlog,Philippe Remy,Christopher Robin,G. Rodier,Jérôme Romero,Brigitte Roualdès,F. Rouhart,I. Ruggieri,Feras Abdul Samad,I. Sarafiant,M. Schaeffer,Nicolas Schmidt,P. Schuermans,Nicolas Seiller,T Soisson,A. Sortais,Bruno Stankoff,Sabrina Stefanizzi-Debuc,L. Suchet,Jean-Noël Tardy,Gregory Taurin,Florent Thabuy,Marie Théaudin,Caroline Tilikete-Froment,Ayman Tourbah,P. Tourniaire,S Tréfouret,Michel Vastene,Pierre Verdure,Patrick Vermersch,Frédérique Viala,Dorothée Videt-Gibou,Elisabeth Vidry,Sandra Vukusic,Marc Wagner,Valery Wattier,Christophe Zaenker,Francois Ziegler,J. M. Zola +210 more
TL;DR: In this paper , the authors evaluated the effectiveness of fingolimod 0.5 mg in reducing the annualised relapse rate (ARR) in patients with relapsing-remitting multiple sclerosis.